January 2010
DN Venture Partners was in China with a client to study the pharmaceutical sector in Shanghai, Suzhou and Hangzhou. Also,
Adamant Biomedical Investments AG, a Swiss fund manager focusing on the healthcare sector, has appointed DN Venture Partners to support its activities in Asia, including China. For more information about Adamant, you may visit http://www.adamantinvest.com. |